Skip to main content
Fig. 3 | BMC Public Health

Fig. 3

From: Impact of vaccine delays at the 2, 4, 6 and 12 month visits on incomplete vaccination status by 24 months of age in Quebec, Canada

Fig. 3

Distribution of total vaccine delays by visit with first (new) vaccine delay, 2006–2016*. *Both cohorts included. DTaP1 was recommended at 2 months, DTaP2 at 4 months, DTaP3 at 6 months and the first measles-containing vaccine at 12 months. Categories of vaccine delays were mutually exclusive. The maximum number of delayed doses was 4 for a first (new) delay at 2 months, 3 at 4 months, 2 at 6 months and 1 at 12 months

Back to article page

BMC Public Health

ISSN: 1471-2458

Contact us